Intrinsic uncoupling of cytochrome c oxidase may cause the maternally inherited mitochondrial diseases MELAS and LHON  by Mather, Michael W & Rottenberg, Hagai
Intrinsic uncoupling of cytochrome c oxidase may cause the maternally
inherited mitochondrial diseases MELAS and LHON
Michael W. Mather, Hagai Rottenberg*
Department of Pathology and Laboratory Medicine, MCP/Hahnemann School of Medicine, Allegheny University of the Health Sciences,
M.S. 435, Broad and Vine Streets, Philadelphia, PA 19102, USA
Received 14 May 1998
Abstract Mutations in the human mtDNA gene encoding
subunit III of cytochrome c oxidase (CO) have been reported
to cause MELAS and LHON. Paracoccus denitrificans cells
expressing substitutions homologous to these MELAS- and
LHON-causing mutations had lower growth yield than wild type
cells and lower efficiency of proton pumping by CO (e.g. lower
H+/e3 ratio and lower v8), but had similar CO activity. These
results indicate that both substitutions (F263LsA212T) cause
intrinsic uncoupling, which may be the direct cause of the
diseases. These results also suggest that subunit III is involved in
proton pumping.
z 1998 Federation of European Biochemical Societies.
Key words: Mitochondrial disease; Cytochrome c oxidase;
Proton pumping; Membrane potential ;
Paracoccus denitri¢cans
1. Introduction
Mutations in mitochondrial DNA (mtDNA) can lead to a
number of maternally transmitted degenerative disorders [1].
In most cases these mutations are associated with a signi¢cant
reduction of the activity of one or more of the mitochondri-
ally encoded enzyme complexes, which is believed to be the
direct cause of the clinical syndromes. Mutations in tRNA-
(LEU), most commonly the substitution A3243G, usually re-
sult in a severe clinical syndrome ^ myoclonic encephalomy-
opathy with lactic acidosis and stroke-like episodes (MELAS).
However, the same substitution may alternatively result, in
other patients, in diabetes mellitus and deafness or in less
common syndromes [2]. Additionally, three rare cases of
MELAS were described that resulted from point mutations
in peptide-encoding genes ^ NADH dehydrogenase genes
ND1 (T3308C) [3], and ND5 (G13513A) [4], and cytochrome
c oxidase subunit III gene (COIII (T9957C)) [5].
More commonly, point mutations in electron transport
complexes result in a much milder syndrome ^ Leber’s heredi-
tary optic neuropathy (LHON). The most common mutations
that cause LHON are three point mutations in NADH dehy-
drogenase peptides: ND1 (G3460A), ND4 (G11778A) and
ND6 (T14484C) [1]. However, a few cases of LHON-associ-
ated point mutations in the COIII gene (COIII (G9438A) and
COIII (G9804A)) were also reported [6]. Evidently, speci¢c
substitutions in the same polypeptide-coding gene can result
in very di¡erent pathologic syndromes. For example, COIII
G9804A produces an A200T substitution in subunit III, which
can cause LHON, while COIII T9957C produces an F251L
substitution, resulting in MELAS. No change in cytochrome c
oxidase (CO) activity was reported for these patients, leaving
open the question of the mechanism by which the latter mu-
tations cause either MELAS or LHON.
CO reduces O2 to water, in a reaction that is coupled to the
generation of the mitochondrial electrochemical proton gra-
dient, vWH [7]. In eukaryotes, the three largest subunits are
encoded by the mtDNA, and up to 10 additional subunits by
nuclear genes. Similar bacterial oxidases contain homologs of
subunits I^III. The recent determination of high resolution
structures for the CO from beef heart [8] and that from the
bacterium Paracoccus denitri¢cans [9] con¢rmed the high de-
gree of structural similarity between the core subunits of the
mammalian and bacterial enzymes previously predicted from
the high degree of sequence similarity. Subunits I and II con-
tain the metal cofactors (Cu, Fe) and catalyze electron trans-
fer (subunit II) and oxygen reduction (subunit I). Subunit I
also participates in proton consumption and proton pumping.
However, subunit III has no well-established function.
In order to gain further insight into the role of CO subunit
III, while at the same time investigating the molecular mech-
anisms by which MELAS- and LHON-causing mutations
produce their pathological e¡ects, we have introduced muta-
tions in COIII from P. denitri¢cans homologous to three mi-
tochondrial mutations proposed to cause LHON or MELAS.
We found that the MELAS mutation and one LHON muta-
tion cause intrinsic uncoupling of CO, which may explain
their pathological e¡ects and supports the suggestion that
subunit III plays an important role in proton pumping.
2. Materials and methods
2.1. Bacterial growth and genetics
P. denitri¢cans strains were grown aerobically in Ludwig’s succinate
medium [10]. Mutations were prepared using the Altered Sites in vitro
mutagenesis system (Promega) with minor modi¢cation. Details and
sequences of the mutagenic primers available on request. Mutated
COIII genes were subcloned into a derivative of pMS13 [11] and
were mobilized into P. denitri¢cans TN-57 [11] for expression by con-
jugation as described [12], using Escherichia coli S17-1 [13] as the
donor host.
2.2. Cell starvation
Cells (200 ml) were harvested during exponential growth at an A690
of 1.0^1.1, and the protein content was determined [14]. The cells were
washed (U2) in one-fourth volume 200 mM KCl, 1.5 mM HEPES,
pH 7.4 and collected by centrifugation (10 min, 6000Ug). Cells to be
used in proton pumping experiments were washed a third time, resus-
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pended in one-half volume of the same solution, and incubated at
30‡C for 1 h with moderate shaking. The starved cells were collected
and resuspended in 200 mM KCl, 1.5 mM HEPES (pH 7.4), 2.5 mM
MgCl2 (weakly bu¡ered KCl medium) at V16^24 mg protein/ml.
Cells to be used in TPP uptake measurements (v8 determination)
were washed again in 160 mM KCl, 50 mM HEPES (pH 7.4), 10 mM
NaCl, 2 mM MgCl2, resuspended in one-half volume 150 mM KCl,
50 mM HEPES (pH 7.4), 5 mM Na2HPO4, 1 mM MgCl2 (bu¡ered
KCl medium), and incubated at 30‡C for 1 h. The starved cells were
collected and suspended in bu¡ered KCl medium (V16^24 mg pro-
tein/ml).
2.3. Determination of turnover number
Membranes were prepared as described [11,15] and used immedi-
ately. The cytochrome content was determined after extraction with
2% dodecyl maltoside, as described [11]. Di¡erence spectra were cal-
culated by digital subtraction, dithionite reduced minus ferricyanide
oxidized. Cytochrome concentrations were calculated after the meth-
od of Vanneste [16], with extinction coe⁄cients extracted from pub-
lished spectra of P. denitri¢cans cytochromes [15,17]. Oxygen con-
sumption was measured with a Clark-type oxygen electrode in a 1.5
ml stirred cell; each membrane sample was incubated at 25‡C in
bu¡ered KCl medium containing 10 WM myxothiazol for 10 min prior
to addition of 10 mM ascorbate+0.2 mM TMPD.
2.4. Determination of proton translocation (H+/O ratio)
The H/O ratios were determined using the oxygen pulse method
[18]. Starved cells were incubated anaerobically under Ar gas for 1 h
in a special stirring cuvette in a reaction medium of 100 mM KCl, 100
mM KSCN, 0.5 mM HEPES (pH 7.4), 0.5 mM MgCl2, 60 WM phenol
red, 20 WM myxothiazol and 30 WM rotenone. As required, 0.2N
KOH was added to maintain the pH near 7.4. Proton pumping was
initiated by injection of 15 Wl low CO2 air-saturated 150 mM KCl
solution (14.1 nmol oxidizing equivalents), and observed as a decrease
in the absorbance of phenol red [19], calibrated by injection of 15 Wl
anaerobic 1 mM HCl in 150 mM KCl.
2.5. Measurement of TPP+ uptake and v8
v8 was estimated from the uptake of tetraphenyl phosphonium
(TPP) [20], using a TPP-sensitive electrode [21]. The assays were
conducted in 4 ml oxygen-saturated bu¡ered KCl medium containing
4 WM TPP. 200 Wl of concentrated starved cell suspension (V3.6 mg
protein) was added, followed by myxothiazol to 20 WM, and the assay
mixture incubated 20 min with stirring. Ascorbate and TMPD were
then added to 10 mM and 0.2 mM (see Fig. 4A). The TPP ratio (15
min after substrate addition) was calculated using 4.78 Wl/mg protein
as the internal volume of P. denitri¢cans cells [22], and was corrected
for non-speci¢c binding of TPP to NaN3-treated cells (0.6 nmol
TPP/mg protein). The ascorbate plus TMPD oxidase activity of
starved cells was measured with the oxygen electrode in bu¡ered
KCl medium with 20 WM myxothiazol and 30 WM rotenone, but with-
out TPP.
3. Results
COIII variants with mutations equivalent to those proposed
to cause LHON (A212T and G85S) or MELAS (F263L) were
expressed in a P. denitri¢cans host strain that has a chromo-
somal deletion removing the gene coding for COIII. During
exponential growth, the growth rates of the P. denitri¢cans
COIII mutant strains were virtually the same as that of the
complemented strain expressing wild type (wt) COIII. How-
ever, the growth of the F263L strain, and to a lesser extent,
that of the A212T strain, slowed during early stationary
phase, and the ¢nal cell density of F263L cultures is consid-
erably lower than that of the complement, suggesting less
e⁄cient metabolism resulting in a lower growth yield (Fig. 1).
P. denitri¢cans strains expressing the A212T, F263L, and
G85S COIII variants contain similar amounts of cytochromes
in their cell membranes as does the complemented strain ex-
pressing the wt subunit III, when measured in situ in cell
suspensions (not shown) or in the membrane fraction isolated
from lysed cells (Fig. 2A). The cellular oxidase activities of the
cells expressing the COIII mutations were not signi¢cantly
di¡erent than the wt activity (347 þ 7, 328 þ 24, 315 þ 36,
and 294 þ 18 ng AO/min/mg protein for the A212T, F263L,
G85S, and wt strains, respectively). Similarly, the turnover
numbers measured in cell membranes were not signi¢cantly
di¡erent from that of the complement (Fig. 2B).
The proton-pumping stoichiometry of CO containing each
mutated COIII subunit was assessed by the oxygen pulse
method, following a short starvation step to reduce endoge-
nous electron transport activity, as described in Section 2. It
was observed that the H/e3 stoichiometry of the A212T and
of the F263L cells was signi¢cantly less than that of the wt
cells, while the G85S stoichiometry was about the same (Fig.
3A). The average measured stoichiometries of the F263L and
the A212T cells, 0.5 and 0.6 H/e3 respectively (corrected for
the chemical release of 0.5 H upon oxidation of ascorbate;
Fig. 3B), are signi¢cantly lower than that of the wt (P6 0.001
for F263L, and P6 0.01 for A212T). The average H/e3 stoi-
chiometry of the G85S strain was somewhat lower than the
wt, but the di¡erence was not statistically signi¢cant. The
stoichiometry of 0.8 H/e3 measured for the wt strain using
ascorbate as reductant is essentially the same as that previ-
ously reported for P. denitri¢cans [23].
We measured v8 from the uptake of TPP in starved P.
denitri¢cans cell suspensions at pH 7.4 (where the vpHW0).
Starved cells maintain a reduced v8, which is largely reversed
upon the addition of cyanide and azide (not shown). Upon
the addition of ascorbate and TMPD, CO pumps and con-
sumes protons, thus increasing the membrane potential (Fig.
4A). The average total potential generated upon ascorbate
addition in suspensions of wt cells was 146 þ 2 mV, similar
to values previously determined for these cells [22]. The up-
take of TPP by F263L cells and A212T cells was always less
than that of wt complemented cells (Fig. 4A). The average v8
of F263L and A212T cells was signi¢cantly less than that
produced by wt cells (P6 0.00001) (Fig. 4B). There was no
signi¢cant di¡erence in the v8 generated by G85S and wt
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Fig. 1. Representative stationary phase growth curves of COIII mu-
tant and wt complemented P. denitri¢cans cultures. Exponentially
growing bacterial cells were inoculated into fresh, pre-warmed me-
dia, each at the same initial density.
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cells. The uptake of TPP by F263L cells reached a maximum
after 15^20 min, and then declined slowly, while wt cells (and
G85S cells) maintained the accumulated TPP for at least 30
min. Thus, it appears that F263L cells not only generate lower
v8 by CO, but cannot maintain the generated v8 over time.
4. Discussion
4.1. The etiology of mitochondrial diseases caused by mutations
in COIII
We have constructed mutations in COIII of P. denitri¢cans
homologous to mutations in human COIII that were reported
to cause MELAS (F263L) or LHON (A212T and G85S).
More recent reports indicate that the G85S is not a pathologic
mutation, but a natural polymorphism that was accidentally
present in the disease cases [24]. This conclusion is in agree-
ment with our ¢ndings that this mutation does not a¡ect the
growth yield of the mutant cells, and has no e¡ect on the
turnover number, H/e3 ratio or the v8 generated by CO.
However, both the LHON-associated (A212T) mutation and
the MELAS-associated (F263L) mutation reduced the growth
yield of the mutant strain, reduced the proton pumping stoi-
chiometry of CO and reduced the magnitude of membrane
potential generated by CO. In all three e¡ects, the enzyme
carrying the MELAS-associated mutation was considerably
more strongly a¡ected than the enzyme carrying the LHON-
associated mutation. Thus the degree of reduction in energy
coupling caused by the mutations in P. denitri¢cans COIII
parallels the severity of the symptoms caused by the corre-
sponding mutations in human CO. Most previous studies as-
sumed that the mitochondrial dysfunction in the various
mtDNA diseases resulted from a reduction in activity of elec-
tron transport complexes or ATP synthase [1,2]. However, it
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Fig. 3. Proton translocation by starved P. denitri¢cans cells. A:
Representative proton pumping assays. B: Average H/e3 values
from batches (n) of wt (n = 8), A212T (n = 3), F263L (n = 3), and
G85S (n = 3) cells (v 3 measurements with each batch). **P6 0.01
and ***P6 0.001, H/e3 values signi¢cantly di¡erent from the ratio
of wt cells.
Fig. 4. Membrane potential generated by starved P. denitri¢cans
cells. A: Uptake of TPP by starved cells before and after addition
of ascorbate+TMPD (oxidase substrate). Two aliquots of TPP (8
nmol) were added before the cells to charge the solution and cali-
brate the electrodes. Downward de£ection of the trace indicates
TPP uptake (lower external concentration). B: Average v8 calcu-
lated from TPP uptake measurements with batches (n) of wt
(n = 6), A212T (n = 3), F263L (n = 5), and G85S (n = 3) cells.
****P6 0.00001, v8 values signi¢cantly di¡erent from the value of
wt cells.
Fig. 2. Cytochrome content and oxidase activity of membranes
from P. denitri¢cans strains. A: Reduced minus oxidized absorbance
di¡erence spectra of detergent extracted membranes from cells ex-
pressing mutated and wt COIII. B: Ascorbate+TMPD oxidase spe-
ci¢c activity (turnover number) of membranes prepared from P. de-
nitri¢cans cells (average of three preparations each).
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has been pointed out frequently (cf. [25]) that there is a large
reserve capacity for most of these complexes, and that it is
necessary to inhibit complex activity by at least 80^90% to
a¡ect oxidative phosphorylation. In many cases, the inhibition
that is observed is modest and is not su⁄cient to account for
the mitochondrial dysfunction. Our data suggest that intrinsic
uncoupling of the mitochondrial complexes (i.e. reduced e⁄-
ciency of vWH generation) may be a direct cause of mitochon-
drial dysfunction in many cases of MELAS and LHON, and
possibly in other mtDNA diseases. Although the magnitude
of these e¡ects in the P. denitri¢cans enzymes is not large, it is
possible that the e¡ects on the human enzyme are larger.
Moreover, a 10^20 mV reduction in maximal v8 could
greatly reduce the rate of ATP synthesis, and perhaps more
importantly, the magnitude of the phosphate potential, (ATP/
(ADPUPi)), that can be generated in the cell. It should be
pointed out that all the peptides coded by mtDNA are essen-
tial membrane-embedded subunits of proton pumping com-
plexes, and in most cases are involved directly or indirectly in
proton pumping. It is therefore likely that many mutations in
these peptides would result in proton leaks.
4.2. The role of subunit III in proton pumping
and energy conversion
The crystal structures of CO (PDB structure #10CC [8,9])
show that subunit III is composed of seven transmembrane
helices (TM). The ¢rst two (TMI^TMII), which are less con-
served, form one domain apart from a ¢ve helix bundle, which
is highly conserved. From the ¢ve helix bundle (TMIII^
TMVII) only TMIII interacts with subunit I next to what
appears to be a pore (now called the D channel), which is
believed to be the pumped protons pathway from the mito-
chondrial matrix into the core of subunit I [26]. The other
four helices, TMIV^TMVII, form a four helix bundle of tilted
helices that appears to form a pore that is open to the cyto-
plasmic surface, resembling the structures of four helix ion
channels (cf. [27,28]).
The subunit III-less enzyme can still couple O2 reduction to
proton pumping, but reportedly with a decreased extent [29],
much reduced rate [30], and lower thermodynamic e⁄ciency
[31]. The subunit III-deleted enzyme also inactivates rapidly
during continuous turnover [32]. The fact that subunit III in
human CO is the site of several disease-causing mutations
suggests that the subunit plays some role in mitochondrial
energy metabolism. Substitution of neutral amino acids for
two conserved, membrane-embedded, acidic residues in sub-
unit III of P. denitri¢cans CO (E97A and D258A), did not
signi¢cantly a¡ect proton pumping (i.e. H/e3 ratios) [30].
However, we have found that these mutations inhibited CO-
driven ATP synthesis, and one mutation (E97A), also inhib-
ited the generation of vWH [22]. All the subunit III point
mutations that have been found to a¡ect proton pumping
and/or energy conversion are in the same peptide domain,
either in the core of this bundle or just above the core, closer
to the periplasmic surface. The MELAS-associated F263L
mutation described here is on TMVII one and a half turns
above (closer to the periplasmic surface) the D258 residue,
which was shown previously to play a role in energy conver-
sion [22]. The A212T mutation is on the adjacent TMVI one
turn above a highly conserved histidine, H216, which is in the
center of the four helix bundle. A conserved serine residue in
yeast COIII (S203), the mutation of which was reported to
inhibit aerobic growth, is also on TMVI, closer to the peri-
plasmic surface [33]. Finally, the DCCD-reactive glutamate
E97 (TMIII), which was previously thought to be involved
in proton translocation [34], and was recently shown to be
important for optimal energy conversion and the generation
of v8 [22], is connected by a hydrogen bond chain to another
conserved histidine on TMVI, H219, through a conserved
tyrosine on TMVII (Y253) (see PDB structure #10CC).
These observations suggest that the periplasmic side of the
four helix bundle of subunit III, and particularly TMVI and
TMVII, play an important role in proton pumping and energy
conversion. While the mechanism of proton pumping by CO
is still largely unknown, it should be noted that to date all
members of the Fe-Cu oxidase superfamily that maintain the
conserved residues in subunit I thought to be important for
the D channel proton pathway also contain a subunit III, and
those oxidases that lack most of these residues also lack sub-
unit III [35].
We suggest that a four helix bundle of subunit III (TMIV^
TMVII) constitutes an exit channel for pumped protons in
CO. There is evidence that protons are taken up by CO
into subunit I through the D channel up to a conserved glu-
tamate residue at the core of the membrane (E278 on helix VI
of subunit I) [36]. However, the proton pathways across the
membrane into the periplasmic space are not yet known. It is
possible that a proton pathway exits, most likely composed of
water molecules, from E278 on subunit I to E97 on subunit
III. It was previously suggested, on the basis of the crystal
structure, that a pathway for molecular oxygen exists along
this route [37]. It is possible that this is a water ¢lled channel
that can conduct protons. Because E97 is hydrogen bonded to
H219 on TMVI, a proton that reaches E97 could reach the
core of the four helix bundle and from there di¡use to the
periplasmic surface.
4.3. Subunit VIa and the control of human CO function
Another observation that is compatible with our explana-
tion and may be relevant to the pathological e¡ects of these
mutations comes from studies of the role of subunit VIa. In
the bovine heart enzyme (which is very similar to the human
enzyme), subunit VIa interacts only with subunit III. The out-
er compartment tail of this subunit is situated on top of the
outer compartment loops (periplasmic in the bacterial en-
zyme) of the four helix bundle blocking the hypothetical pro-
ton exit channel [8]. The role of subunit VIa in CO function is
largely unknown. However, in the heart isoform, ATP binds
to subunit VIa, and causes a reduction of the H/e3 ratio of
the enzyme [38]. The behavior of the ATP-reacted heart en-
zyme, is similar to the behavior of the subunit III mutants
described in this study. It is thus not unlikely that the disease-
causing human mutants are not only intrinsically uncoupled
but are also defective in the ability of subunit VIa to modulate
their function.
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